✦ LIBER ✦

Pharmacokinetic aspects of naloxone-precipitated morphine withdrawal in male and female prepubertal mice

✍ Scribed by Silvina L. Diaz; María P. Hermida; Leonel D. Joannas; Mónica Olivera; Adriana Ridolfi; Edda C. Villaamil; Graciela N. Balerio

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 114 KB
Volume: 28
Category: Article
ISSN: 0142-2782
DOI: 10.1002/bdd.554

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of the effect of levodopa and

Comparison of the effect of levodopa and bromocriptine on naloxone-precipitated morphine withdrawal symptoms in mice

✍ Morteza Samini; Rashin Fakhrian; Massoud Mohagheghi; Ahmad Reza Dehpour 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

In this study, the effect of l-dopa and bromocriptine on morphine withdrawal syndrome was compared. Both l-dopa (125, 250 mg/kg, i.p.) and low doses of bromocriptine (0.04, 0.08 mg/kg, i.p.) potentiated naloxone-induced morphine withdrawal symptoms such as jumping, climbing and rearing in mice. High

Effect of NMDA receptor antagonist on na

Effect of NMDA receptor antagonist on naloxone-precipitated withdrawal signs in cholestatic mice

✍ Ahmad Reza Dehpour; Morteza Samini; Hossein Rastegar; Abazar Jamshidi Ardeshiri; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 2 views

The ability of NMDA antagonist MK-801 to block the expression of opioid-like withdrawal signs was examined in bile duct-ligated mice and the signs were compared with sham operated and unoperated animals. Administration of MK-801 (0/1 mg/kg), 10 min prior to naloxone challenge, significantly reduced